ALLR 8-K 2026-06-22

Allarity Therapeutics, Inc. (ALLR) 8-K dated 2026-06-22 — accession 0001213900-26-070382. This URL is the filing, not the ALLR hub.

Allarity Therapeutics, Inc. (ALLR) is a biotechnology company listed on US.

Allarity Therapeutics, Inc. filed a 8-K on 2026-06-22. Accession 0001213900-26-070382.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.

Not investment advice. The ALLR SEC hub lists recent forms. The stock page is the research view.